A. J. Robichaud, B. L. Largent (2000). Recent advances in selective serotonin receptor modulation.
Ann. Rep. Med. Chem. 35: 11.
D. V. S. Sankar (1975). LSD:A Total Study. Westbury, New York: PJD Publishing.
P. R. Saxena (1995). Serotonin receptors: subtypes, functional responses and therapeutic rele-
vance. Pharmacol. Ther. 66: 339.
H. Sternbach (1991). The serotonin syndrome. Am. J. Psychiatry 148: 705.
L. H. Tecott, D. Julius (1993). A new wave of serotonin receptors. Curr. Opin. Neurobiol. 3: 310.
S. C. Veasey (2003). Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic
potential.Am. J. Resp. Med. 2: 21–29.
S. P. Vickers, M. J. Bickerdike, C. T. Dourish (1999). Serotonin receptors and obesity. Neurosci.
News 2: 22–28.
H. Wang (2003). Serotonin receptor as a potential therapeutic target for pulmonary vascular
remodeling.Drug Dev. Res. 58: 69–73.
Histamine and Histamine Receptors
L. F. Alguacil, C. Perez-Garcia (2003). Histamine H3 receptor: A potential drug target for the treat-
ment of central nervous system disorders. Curr. Drug Targets:CNS Neurol. Dis. 2 : 303–313.
R. A. Bakker, H. Timmerman, R. Leurs (2002). Histamine receptors: specific ligands, receptor
biochemistry, and signal transduction. Clin. All. Immunol. 17: 27–64.
B. S. Bochner, L. M. Lichtenstein (1991). Anaphylaxis. New Engl. J. Med. 324: 1785.
T. H. Brown, R. C. Young (1985). Antagonists of histamine at its H 2 -receptor. Drugs of the Future
10 : 51–69.
F. M. Cuss (1999). Beyond the histamine receptor: effects of antihistamines on mast cells. Clin.
Exper. Allergy 29: 54.
J. Del Valle, I. Gantz (1997). Novel insights into histamine H2 receptor biology. Am. J. Physiol.
273 : G987.
J. P. Desager, Y. Horsmans (1995). Pharmacokinetic–pharmacodynamic relationships of H1-anti-
histamines.Clin. Pharmacokinet. 28: 418.
G. J. Durant (1979). Chemical aspects of histamine H 2 -receptor agonists and antagonists. In:
F. Gualtieri, M. Gianella, C. Melchiorre (Eds.). Recent Advances in Receptor Chemistry.
New York: Elsevier/North Holland, pp. 245–266.
M. Feldman, M. E. Burton (1990). Drug therapy: H2 receptor antagonists. New Engl. J. Med.
323 : 1672.
C. R. Ganellin, M. E. Parsons (Eds.) (1982). Pharmacology of Histamine Receptors. Bristol:
Wright PSG.
C. R. Ganellin, J.-C. Schwartz (Eds.) (1985). Frontiers in Histamine Research.New York:
Pergamon.
G. L. Garay, J. M. Muchowski (1985). Agents for the treatment of peptic ulcer disease. Annu.
Rep. Med. Chem. 20: 93–105.
J. G. Gleason, C. D. Perchonock, T. J. Torphy (1986). Pulmonary and antiallergy agents. Annu.
Rep. Med. Chem. 21 : 73–83.
E. E. J. Haaksma, R. Leurs, H. Timmerman (1990). Histamine receptors: subclasses and specific
ligands.Pharmacol. Ther. 47: 73.
S. T. Holgate (1999). Antihistamines: back to the future. Clin. Exper. Allergy 29: Suppl. 3.
D. MacGlashan, Jr (2003). Histamine: a mediator of inflammation. J. All. Clin. Immunol. 112:
S53–S59.
H. J. Nielsen (1996). Histamine-2 receptor antagonists as immunomodulators: new therapeutic
views. Ann. Med. 28: 107.
NEUROTRANSMITTERS AND THEIR RECEPTORS 305